Wooster, OH, United States of America

Sankar Renu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Sankar Renu

Introduction

Sankar Renu is an accomplished inventor based in Wooster, OH (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for poultry. With a total of 2 patents, his work focuses on addressing critical health issues in poultry farming.

Latest Patents

One of his latest patents is a poultry vaccine for clostridium perfringens. This invention relates to nanoparticle compositions designed for use as vaccines against necrotic enteritis in poultry. The compositions include one or more extracellular proteins entrapped in a polyanhydride or chitosan nanoparticle. These proteins may consist of various toxins, such as alpha toxin (CPA), beta toxin (CPB), epsilon toxin (ETX), iota toxin (ITX), perfringolysin O (PFO), enterotoxin (CPE), beta2 toxin (CPB2), or NetB toxin. Additionally, the composition may include a flagellar protein. The invention also encompasses methods for the oral delivery of these proteins to the mucosal membrane of the intestinal tract of birds of the order Galliformes.

Career Highlights

Sankar Renu has worked with notable institutions, including the University of Georgia Research Foundation, Inc. and The Ohio State University. His experience in these organizations has contributed to his expertise in vaccine development and research.

Collaborations

He has collaborated with esteemed colleagues such as Renukaradhya Gourapura and Ramesh Kumar Selvaraj. These partnerships have further enhanced his research capabilities and innovation in the field.

Conclusion

Sankar Renu's contributions to poultry health through innovative vaccine development highlight his role as a significant inventor in veterinary medicine. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…